Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Prothena Corp (NQ: PRTA )

21.64 -0.35 (-1.59%)
Streaming Delayed Price Updated: 11:31 AM EDT, Apr 16, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 103,982
Open 21.67
Bid (Size) 21.61 (2)
Ask (Size) 21.67 (2)
Prev. Close 21.99
Today's Range 21.31 - 22.14
52wk Range 21.59 - 79.65
Shares Outstanding 45,047,449
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Prothena Announces Review on Birtamimab Mechanism of Action and Pharmacological Characteristics Published in Leukemia & Lymphoma
From Prothena Corporation plc
Via Business Wire
Race To Treat Alzheimer's Disease Is Heating Up Despite Eli Lilly's Setback
The FDA has delayed making a decision on Eli Lilly's donanemab, pending an advisory committee meeting. 
Via Investor's Business Daily
Exposures Product Safety

Performance

YTD
-43.85%
-43.85%
1 Month
-13.75%
-13.75%
3 Month
-34.66%
-34.66%
6 Month
-58.64%
-58.64%
1 Year
-59.38%
-59.38%

More News

Read More
Demystifying Prothena Corp: Insights From 8 Analyst Reviews
Via Benzinga
Prothena to Participate in Upcoming Healthcare Conferences
From Prothena Corporation plc
Via Business Wire
Decoding 6 Analyst Evaluations For Prothena Corp
Via Benzinga
Prothena Corp: Q4 Earnings Insights
Via Benzinga
Earnings Scheduled For February 15, 2024
Via Benzinga
Prothena Appoints David Ford to Newly Created Chief People Officer Position
From Prothena Corporation plc
Via Business Wire
10 Health Care Stocks Whale Activity In Today's Session
Via Benzinga
Prothena Announces Appointment of Daniel G. Welch as Director and Chair Designate
From Prothena Corporation plc
Via Business Wire
Prothena Reports Fourth Quarter and Full Year 2023 Financial Results, and Provides Financial Guidance and Business Highlights
From Prothena Corporation plc
Via Business Wire
Earnings Outlook For Prothena Corp
Via Benzinga
Navigating 5 Analyst Ratings For Prothena Corp
Via Benzinga
Prothena to Report Fourth Quarter and Full Year 2023 Financial Results on February 15, 2024
From Prothena Corporation plc
Via Business Wire
Why UPS Shares Are Trading Lower By 8%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
$100 Invested In Prothena Corp 5 Years Ago Would Be Worth This Much Today
Via Benzinga
Demystifying Prothena Corp: Insights From 5 Analyst Reviews
Via Benzinga
4 Analysts Have This to Say About Prothena Corp
Via Benzinga
Hewlett Packard Enterprise, Hologic And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Topics Stocks
Exposures US Equities
Why RxSight Shares Are Trading Higher By 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Boeing, Pacific Biosciences of California And Other Big Stocks Moving Lower On Monday
Via Benzinga
Topics Stocks
Exposures US Equities
Prothena Provides Updates on PRX012, PRX123, Birtamimab and Portfolio Programs
From Prothena Corporation plc
Via Business Wire
Alzheimer's Disease Vaccines: Promising Developments, Renewed Enthusiasm From Biogen, Eli Lilly And Others
Via Benzinga
Quest For Alzheimer's Cure: Big Biotech Breakthroughs, But The Race Is Just Beginning
Via Investor's Business Daily
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.